دورية أكاديمية
397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study
| العنوان: | 397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study |
|---|---|
| المؤلفون: | Martinelli, E., Martini, G., Troiani, T., Pietrantonio, F., Avallone, A., Normanno, N., Nappi, A., Maiello, E., Falcone, A., Santabarbara, G., Pinto, C., Santini, D., Ciardiello, D., Terminiello, M., Borrelli, C., Napolitano, S., Renato, D., Famiglietti, V., Esposito, L., Ciardiello, F. |
| المصدر: | Annals of Oncology ; volume 31, page S409-S410 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2020.08.508 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2020.08.508Test https://api.elsevier.com/content/article/PII:S0923753420405046?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753420405046?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.85D364EB |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2020.08.508 |
|---|